espacenet — Bibliographic data
Page 1 of 1
C-MPL LIGAND AGONIST ANTIBODY
Publication number: JP9289892 (A)
Publication date:
Inventor(s):
Applieant(s):
Classification:
- international:
1997-11-11
YANO SHINYA; ABE MASAKI; SAKABA NANA; URASAKI TETSUYA; NAKADA
SUSUMU +
YAMANOUCHI PHARMA CO LTD +
A61K38/00; A61K39/395; AB1P7/00; C07H21/04; C07K16/00; C07K16/18;
C07K19/00; C12N15/09; C12N5/00; C12N5/10; C12P21/02; C12P21/08; C12R1/91;
A61K38/00; A61K39/395; A61P7/00; C07H21/00; C07K16/00; C07K16/18;
C07K19/00; C12N15/09; C12N5/00; C12N5/10; C12P21/02; C12P21/08; (IPC1-
7): AB1K38/00; A61K39/395; C07H21/04; C07K16/18; C12N15/09; C12N5/10;
C12N5/10; C12P21/02; C12P21/02; C12P21/08; C12P21/08; C12R1/91; C12R1/91;
C12R1/91
- European:
Application number: JP1 99601 051 01 19960425
Priority number(s): JP19960105101 19960425
Abstract of JP 9289892 (A)
PROBLEM TO BE SOLVED: To obtain a new gene coding a chimeric protein containing an extracellular
domain of c-MPL and a cell membrane-penetrating through type proteins other than the domain and used
for treating aplastic anemia, malignant tumor, thrombocytepenia, etc. SOLUTION: This new gene codes a
chimeric protein containing an extracellular domain of c-MPL or its part and a cell membrane-penetrating
through type protein or its part and is useful for producing the chimeric protein necessary for preparation of
c-MPL ligand agonist antibody and the antibody and the protein are effective for chemotherapy of aplastic
anemia, malignant tumor, etc. and treatment of thrombocytepenia accompanied by radiotherapy and
thrombocytepenia accompanied by bone marrow transplantation. The DNA is obtained by extracting mRNA
from HEL 92.1 .7 cell, synthesizing its cDNA, cloning the cDNA by PCR method using a primer and binding
the resultant DNA of extracellular domain of c-MPL to DNA of interleukin-2 receptor, etc.
Data supplied from the espacenet database — Worldwide
http://v3xspacenetxomfoublicati 11/12/2010
(19)H*BHWW (JP) 02) & H ij^ §^ & (A) (lOttttOWftll**
!|#W¥9 - 289892
(43)&iHB ¥fiK9^(1997)limiB
(51) IntCl. 6
C 1 2 N 15/09
A 6 1 K 38/00
39/395
C0 7H 21/04
ZNA 9282 -4B
ABY
F I
C12N 15/00
A 6 1 K 39/395
C0 7H 21/04
C0 7K 16/18
ZNAA
N
AB YD
B
ol (£17 jo mmzm<
(21)ffl«##
wkw- 105101
(71)B«A
000006677
(22)mBB
8 ^(1996) 4 3250
m&mt>;m n *a*»r 2 t b 3 #im
<72)&W#
*tt»-3 < fcfrfrfjTH 2 TB 4 -14-202
(72)»fl#
TO iE«f
£»«ElIJTtrg«l5 4 - 1411 -28
(72)&W#
8*
^*5E*^< Mtfc©fif 1-14- 2
C72>SW»
«*s em
Wmo < «rff=©g 3-13-1
C72)*H#
f BB ii
(74)ft3!A
(54) c-MPLUj?>l*7:*ru*Mftfl£
r * v p r *
hi
O
i
i
CD
(2)